Silvergate Pharmaceuticals Inc., of Denver, said the FDA approved Qbrelis, an oral solution of ACE inhibitor lisinopril, for the treatment of hypertension in adult patients and pediatric patients, 6 and older, as adjunct therapy for heart failure and as treatment of acute myocardial infarction in adults.